BSX · Healthcare
Boston Scientific Corp
48/100
Smart-money confidence2 of 3 sources positive
Moderate — mixed signals
company insiders are buying
Hedge funds
50
Congress
No data
Insiders
100
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
Consensus buy — 2 of 3 sources positive →
Market cap
$74.9B
Industry
Medical Devices
Sector
Healthcare
Exchange
NYSE
About BOSTON SCIENTIFIC CORP
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatography procedures, and single-use duodenoscopes, as…
Who's behind the signal
Every informed buyer we can see on BSX, across all three feeds.
Hedge funds · 9
D.E. Shaw & Co
Increased +116%
Point72 (Steve Cohen)
Increased +52%
AQR Capital Management
Increased +377%
Gotham Asset Mgmt (Greenblatt)
Increased +203%
Tudor Investment (Paul Tudor Jones)
Decreased −14%
Citadel Advisors
Decreased −12%
+3 more in the full breakdown below ↓
Congress · 0
No congressional trades on record.
Insiders
Company insiders
Buying
Recent buys8
Congressional trades · 31 on record
Disclosures from 2020-02-05 to 2022-10-21
The newest disclosure we hold for this stock is 2022-10-21.
That is the end of our data, not necessarily the end of the trading — our
bulk STOCK Act archive stops there and newer filings arrive through a
separate live feed. Treat the absence of recent rows as “not covered”,
not as “no trades”.
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2022-10-21 | Alan S. Lowenthal · D-CA | House | Sold | $1,001 - $15,000 |
| 2021-12-16 | Robert J. Wittman · R-VA | House | Sold | $1,001 - $15,000 |
| 2021-08-06 | Alan S. Lowenthal · D-CA | House | Sold | $1,001 - $15,000 |
| 2021-08-03 | Alan S. Lowenthal · D-CA | House | Sold | $1,001 - $15,000 |
| 2021-07-21 | Kevin Hern · R-OK | House | Bought | $15,001 - $50,000 |
| 2021-07-01 | Kevin Hern · R-OK | House | Bought | $100,001 - $250,000 |
| 2021-06-22 | John R. Curtis · R-UT | House | Bought | $1,001 - $15,000 |
| 2021-05-20 | Kevin Hern · R-OK | House | Bought | $1,001 - $15,000 |
| 2021-02-16 | Peter Meijer · R-MI | House | Bought | $1,001 - $15,000 |
| 2021-02-02 | Alan S. Lowenthal · D-CA | House | Bought | $1,001+ |
Show the other 21
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2021-02-02 | Alan S. Lowenthal · D-CA | House | Bought | $1,001 - $15,000 |
| 2021-02-01 | Alan S. Lowenthal · D-CA | House | Bought | $1,001+ |
| 2021-02-01 | Alan S. Lowenthal · D-CA | House | Bought | $1,001 - $15,000 |
| 2021-02-01 | Alan S. Lowenthal · D-CA | House | Bought | $15,001 - $50,000 |
| 2020-12-18 | Dean Phillips · D-MN | House | Sold | $1,001 - $15,000 |
| 2020-11-27 | Michael T. McCaul · R-TX | House | Bought | $15,001 - $50,000 |
| 2020-10-21 | Lois Frankel · D-FL | House | Bought | $1,001 - $15,000 |
| 2020-10-02 | Robert J. Wittman · R-VA | House | Bought | $1,001 - $15,000 |
| 2020-08-10 | Dean Phillips · D-MN | House | Bought | $1,001 - $15,000 |
| 2020-04-14 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2020-04-09 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2020-03-27 | John R. Curtis · R-UT | House | Bought | $1,001 - $15,000 |
| 2020-03-26 | Lois Frankel · D-FL | House | Bought | $1,001 - $15,000 |
| 2020-03-19 | Alan S. Lowenthal · D-CA | House | Sold | $1,001 - $15,000 |
| 2020-03-19 | Alan S. Lowenthal · D-CA | House | Sold | $1,001+ |
| 2020-03-18 | Gilbert Ray Cisneros, Jr. · D-CA | House | Bought | $1,001 - $15,000 |
| 2020-03-18 | Lois Frankel · D-FL | House | Bought | $1,001 - $15,000 |
| 2020-03-13 | Alan S. Lowenthal · D-CA | House | Sold | $1,001+ |
| 2020-03-11 | Alan S. Lowenthal · D-CA | House | Sold | $1,001 - $15,000 |
| 2020-02-27 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2020-02-05 | Mo Brooks · R-AL | House | Sold | $1,001 - $15,000 |
Not a model pick — but on our radar.
BOSTON SCIENTIFIC CORP isn't in the top-10 model right now, but 9 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
9
Investors
0
New positions
4
Increasing
5
Decreasing
0
Unchanged
Price History
Loading price data...
Return:
High:
Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.0×
% of portfolio
1.3%
Position change
+116%
1.3% of D.E. Shaw & Co's portfolio
Trust weight: 1.1×
% of portfolio
0.4%
Position change
+52%
0.4% of Point72's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
+377%
0.1% of AQR Capital Management's portfolio
Trust weight: 1.1×
% of portfolio
0.1%
Position change
+203%
0.1% of Gotham Asset Mgmt's portfolio
Trust weight: 1.2×
% of portfolio
0.2%
Position change
−14%
0.2% of Tudor Investment's portfolio
Trust weight: 1.0×
% of portfolio
0.2%
Position change
−12%
0.2% of Citadel Advisors's portfolio
Trust weight: 1.0×
% of portfolio
0.2%
Position change
−62%
0.2% of Millennium Management's portfolio
Trust weight: 1.4×
% of portfolio
0.1%
Position change
−48%
0.1% of Lone Pine Capital's portfolio
Trust weight: 1.3×
% of portfolio
0.0%
Position change
−18%
0.0% of Bridgewater Associates's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to BOSTON SCIENTIFIC CORP
No insider trades found in the last 90 days
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell BOSTON SCIENTIFIC CORP or any security.
Get the Weekly Update
Every week, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime